104360-70-5

Basic information

• Product Name: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)
• Synonyms: DBI FRAGMENT (HUMAN);DIAZEPAM BINDING INHIBITOR [DBI] FRAGMENT 51-70;DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN);GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS;GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS HUMAN;FRAGMENT (HUMAN) DBI;H-GLN-ALA-THR-VAL-GLY-ASP-ILE-ASN-THR-GLU-ARG-PRO-GLY-MET-LEU-ASP-PHE-THR-GLY-LYS-OH;QATVGDINTERPGMLDFTGK
• CAS NO: 104360-70-5
• Molecular Formula: C91H148N26O32S
• Molecular Weight: 2150.37
• Product Categories: Miscellaneous Compounds;Obesity
• Mol File: 104360-70-5.mol

Chemical Properties

• Appearance: /
• Density: 1.50±0.1 g/cm3(Predicted)
• Storage Temp.: −20°C
• CAS DataBase Reference: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(CAS DataBase Reference)
• NIST Chemistry Reference: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(104360-70-5)
• EPA Substance Registry System: DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN)(104360-70-5)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 104360-70-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is used as a research tool for studying the interaction between diazepam and its binding site in the human body. This helps researchers to understand the biological mechanisms involved and develop new medications that can modulate the effects of diazepam.
Used in Drug Discovery:
DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is used as a lead compound in drug discovery for the development of new medications that can provide alternative treatments for conditions currently managed with diazepam. By blocking the interaction between diazepam and its binding site, this fragment may pave the way for the creation of more effective drugs with fewer side effects.
Used in Medication Optimization:
DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is used as a reference compound in the optimization of existing medications that target the same binding site as diazepam. By understanding how this fragment interacts with the binding site, researchers can modify existing drugs to improve their efficacy and reduce potential side effects.
Used in Neuropharmacology:
DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is used as a research tool in neuropharmacology to study the effects of diazepam on the central nervous system. This can help researchers gain insights into the mechanisms of action of benzodiazepines and develop new treatments for anxiety, seizures, and other neurological disorders.
Used in Toxicology Studies:
DIAZEPAM BINDING INHIBITOR FRAGMENT (HUMAN) is used in toxicology studies to evaluate the potential side effects and toxicity of diazepam and related compounds. By understanding how this fragment interacts with the binding site, researchers can assess the safety and efficacy of new medications and minimize adverse effects.